The Financialization of Disruptive Technology
The Agile Manager
SEPTEMBER 30, 2019
A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. Investment yields are highly concentrated. There are a plenty of analyses to show that a small percentage of investments yield the majority of the gains. Just 4 per cent of investments made half the returns."
45 
Let's personalize your content